Prostate cancer (PCa) is now the most commonly diagnosed cancer in men in the UK despite there being no formal screening programme.1 Prostate-specific antigen (PSA) level can be used as a screening test, with prostate biopsy in men with a raised PSA level allowing histopathological confirmation of the diagnosis of PCa. Here, KLK3 is linked to cancer.